← BackHENRY SCHEIN INC · Medical, Dental & Hospital Equipment & SuppliesHSIC
Low riskNext report: In 6 days (est.)
The short versionA profitable company with steady sales.
Going well
- Profitable every year for 10 years
- Brings in more cash than it spends
- Buying back shares: share count down 12% in 3 years
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 2.2% to their holdings in the quarter ending June 2026 (230 bought, 280 sold)
- Held by Ray Dalio (Bridgewater)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$84.51-0.5% that day
- Company value
- $9.4B
- Share price times all shares
- Price vs profit (P/E)
- 24.6x
- You pay about $25 for each $1 of yearly profit
- Price vs sales
- 0.69x
- Company value is 0.69 times a year of sales
- Cash vs value
- 2%
- Cash as a share of company value
- Debt vs value
- 25%
- Debt as a share of company value
From HSIC's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$3.5B+6.7% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $13.6B, up 6.5% from the 12 months before. Over 5 years, sales grew about 5.4% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.12.6%
- MissDebt under half of equityNot relying on borrowed money.0.71x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.3.2%
- PassProfitable every yearSteady profits, not one good year.10 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$712.0M
- PassShare count not growingNot diluting owners. Falling means buybacks.-11.6% in 3 years
- MissGross margin 40%+Pricing power: sells for well above what it costs to make.31.1%
- Revenue
- $13.2B
- +4.0% vs prior year
- 5-year growth
- +5.4%/yr
- revenue, per year
- Total debt
- $2.3B
- 0.71x equity
- Current ratio
- 1.38x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 27, 2026- Revenue
- $3.5B
- +6.7% YoY
- EPS
- $0.82
- vs $0.70
- Op. margin
- 4.9%
- +0.2 pts
- Gross margin
- 31.8%
- +0.4 pts
- Free cash flow
- $212.0M
- Share count
- -6.7%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.6
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady+2.2%Institutions added 2.2% to their holdings. 230 bought, 280 sold.
Shares held by institutions122.9M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-5.2%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.7x · $2.3B debtShares outstandingLatest reported
111MNext reportIn 6 days (est.)Estimated from the same quarter last year
- Results filedAug 4
- Results filedMay 5
- Results filedFeb 24
- Results filedNov 4, 2025
- Results filedAug 5, 2025
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.